EANS-Adhoc: LifeWatch with solid first quarter 2013 results on track (with document)
2 Documents
-------------------------------------------------------------------------------- ad-hoc disclosure transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is solely responsible for the content of this announcement. -------------------------------------------------------------------------------- Earnings/3-month report/LifeWatch AG 14.05.2013 + Improved revenues of USD 21.02 million in Q1 2013; + Improved EBIT of USD 1.17 million and EBITDA of USD 1.95 million; + Improved gross margin of 59.1%; + Improved cash flow position in Q1 2013; International analyst and media conference and audio web cast on LifeWatch Q1 2013 results: + Tuesday, May 14, 2013 at 10.00 a.m. CEST; + Dial-in number: +41 (0)58 310 50 00 (Europe), +44 (0)203 059 58 62 (UK),+1(1)631 570 56 13 (USA); + Audio web cast http://services.choruscall.eu/links/lifewatch130514.html; Neuhausen am Rheinfall/Switzerland - LifeWatch AG (SIX Swiss Exchange: LIFE), the leading provider of wireless telemedicine, today announces the results for the first quarter 2013. The Company improves its operating profit on EBIT and EBITDA level and shows again a net profit. You will find a PDF-version of this press release and of the letter to shareholders with the results of the first quarter 2013 at the end of this message. First Quarter 2013 Financial Highlights: + Revenues of USD 21.02 million compared with USD 20.07 million in Q4 2012; + Gross margin improved to 59.1% compared with 56.6% in Q4 2012; + EBIT improved to USD 1.17 million compared with USD 0.65 million in Q4 2012; + EBITDA increased to USD 1.95 million compared with USD 1.57 million in Q4 2012 + Net profit of USD 0.14 million compared with USD 0.47 million in Q4 2012; + Cash from operations were USD 5.04 million compared with USD 1.13 million cash used in operations in Q4 2012 In March 2013, the Company announced that its Board member Kenneth Melani will take the Chair of the Board of Directors subject to his re-election at the upcoming ordinary shareholder meeting on May 29, 2013. Long-time Chairman and Chief Executive Officer of LifeWatch AG, Dr. Yacov Geva, will continue to act as the Corporate CEO in order to grow the existing and future business of the Company. The candidature of John Paul announced by the Board of Directors on May 2, 2013, has been withdrawn short-term by personal reasons. Revenues: Revenues in Q1 of 2013 were USD 21.02 million, compared with Q4 2012 revenues of USD 20.07 million. Total monitoring revenues from LifeWatch Services grew by 6.3% compared with Q4 2012 revenues. Gross Profit, EBIT and EBITDA: + Gross profit improved this quarter and reached USD 12.42 million with a margin of 59.1%, compared with USD 11.36 million and a margin of 56.6% in Q4 2012. + EBIT this quarter improved to USD 1.17 million or 5.6% of revenues, compared with EBIT of USD 0.65 million with a margin of 3.2% reported in Q4 2012. + EBITDA also improved in Q1 2013, reaching USD 1.95 million and a margin of 9.3%, compared with EBITDA of USD 1.57 million and a margin of 7.8% reported in Q4 2012. Net Income: Net income in Q1 2013 was USD 0.14 million and a margin of 0.6%, compared with net income of USD 0.47 million with a margin of 2.3% in Q4 2012. Fully diluted earnings per share reached USD 0.01 in Q1 2013, compared with fully diluted earnings per share of USD 0.03 in Q4 2012. Outlook 2013: The company remains focused on improving revenues and profitability. Our improved Q1 2013 results demonstrate our commitment to our shareholders, and we are certain that the new product and service pipeline will provide us with additional opportunities in diverse geographies and consumer markets. About LifeWatch AG: LifeWatch AG, headquartered in Neuhausen am Rheinfall and listed on SIX Swiss Exchange (LIFE), Switzerland, is the leading healthcare technology and solution company, specializing in advanced telehealth systems and wireless remote patient monitoring services. LifeWatch services cater to individuals, ranging from high-risk and chronically ill patients, to consumers of health and wellness products. LifeWatch AG has operative subsidiaries in the United States, in Switzerland and in Israel and is the parent company of LifeWatch Services Inc., and LifeWatch Technologies, Ltd. LifeWatch Services, Inc. is a leading US-based provider of cardiac monitoring services and home sleep testing of Obstructive Sleep Apnea (OSA). LifeWatch Technologies Ltd., based in Israel, is a leading developer and manufacturer of telemedicine products. The Company is planning to introduce the LifeWatch V, an Android-based smartphone with medical sensors and apps that uses a cloud-based service platform. For additional information, please visit www.lifewatch.com. Sign-up for customized E-mail alerts and documentation requests is available at http://production.investis.com/lifewatch/alert-service/ This press release includes forward-looking statements. All statements other than statements of historical facts contained in this press release, including statements regarding future results of operations and financial position, business strategy and plans and objectives for future operations, are forward- looking statements. The words "believe," "may," "will," "estimate," "continue," "anticipate," "intend," "expect" and similar expressions are intended to identify forward-looking statements. LifeWatch AG has based these forward-looking statements largely on current expectations and projections about future events and financial trends that it believes may affect the financial condition, results of operations, business strategy, short term and long term business operations and objectives, and financial needs. These forward-looking statements are subject to a number of risks, uncertainties and assumptions. In light of these risks, uncertainties and assumptions, the forward-looking events and circumstances described may not occur and actual results could differ materially and adversely from those anticipated or implied in the forward- looking statements. All forward-looking statements are based only on data available to LifeWatch AG at the time of the issue of this press release. LifeWatch AG does not undertake any obligation to update any forward-looking statements contained in this press release as a result of new information, future events or otherwise. THIS PRESS RELEASE IS NOT BEING ISSUED IN THE UNITED STATES OF AMERICA AND SHOULD NOT BE DISTRIBUTED TO UNITED STATES PERSONS OR PUBLICATIONS WITH A GENERAL CIRCULATION IN THE UNITED STATES. THIS PRESS RELEASE DOES NOT CONSTITUTE AN OFFER OF SECURITIES OF LIFEWATCH AG OR ANY OF ITS SUBSIDIARIES FOR SALE IN THE UNITED STATES OR AN INVITATION TO SUBSCRIBE FOR OR PURCHASE ANY SECURITIES OF LIFEWATCH AG OR ITS SUBSIDIARIES IN THE UNITED STATES. IN ADDITION, THE SECURITIES OF LIFEWATCH AG AND ITS SUBSIDIARIES HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES LAWS AND MAY NOT BE OFFERED, SOLD OR DELIVERED WITHIN THE UNITED STATES OR TO U.S. PERSONS ABSENT REGISTRATION UNDER OR AN APPLICABLE EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE UNITED STATES SECURITIES LAWS. ANY PUBLIC OFFERING OF SECURITIES TO BE MADE IN THE UNITED STATES WILL BE MADE BY MEANS OF A PROSPECTUS THAT MAY BE OBTAINED FROM LIFEWATCH AG OR ITS SUBSIDIARIES, AS APPLICABLE, AND WILL CONTAIN DETAILED INFORMATION ABOUT THE ISSUER AND ITS MANAGEMENT AS WELL AS FINANCIAL STATEMENTS OF THE ISSUER. Attachments with Announcement: ---------------------------------------------- http://resources.euroadhoc.com/us/yvKBMcrX http://resources.euroadhoc.com/us/VnwXYtUH Further inquiry note: Sensus Communication Consultants, Zürich: Tel +41 43 366 55 11 | Fax +41 43 366 55 12 | Email lifewatch@sensus.ch end of announcement euro adhoc -------------------------------------------------------------------------------- Attachments with Announcement: ---------------------------------------------- http://resources.euroadhoc.com/us/yvKBMcrX http://resources.euroadhoc.com/us/VnwXYtUH issuer: LifeWatch AG Rundbuckstrasse 6 CH-8212 Neuhausen am Rheinfall phone: +41 52 632 00 50 FAX: +41 52 632 00 51 mail: users@lifewatch.com WWW: www.lifewatch.com sector: Healthcare Providers ISIN: CH0012815459 indexes: SPI, SPIEX stockmarkets: free trade: Berlin, Open Market / XETRA: Frankfurt, Main Standard: SIX Swiss Exchange language: English